FDA Issues First Set of Warning Letters to Companies Selling Delta-8 THC
On May 4, 2022, the United States Food and Drug Administration (FDA) issued for the first time Warning Letters to companies selling products containing delta-8 tetrahydrocannabinol (delta-8 THC). While the FDA has sent warnings to companies utilizing hemp-derived cannabidiol (CBD) before, this is the first set of Warning Letters to those selling delta-8 THC products for […]
FDA Issues First Set of Warning Letters to Companies Selling Delta-8 THC Read More »































